Lymphocytic Colitis Is Associated with Increased Pro-Inflammatory Cytokine Profile and Up Regulation of Prostaglandin Receptor EP4

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Dey, Indranil ^a   Beck, Paul L ^b   Chadee, Kris ^a  

^a Health Sciences Centre Calgary   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 23; INTERLEUKIN 4; INTERLEUKIN 8; MESSENGER RNA; PROSTAGLANDIN E RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CANCER SCREENING; CLINICAL ARTICLE; COLON BIOPSY; COLON CANCER; COLON MUCOSA; COLONOSCOPY; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; DIARRHEA; DISEASE ASSOCIATION; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LYMPHOCYTIC COLITIS; MALE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

CASE-CONTROL STUDIES; COLITIS, LYMPHOCYTIC; CYTOKINES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION MEDIATORS; MALE; MIDDLE AGED; RECEPTORS, PROSTAGLANDIN E, EP4 SUBTYPE; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 84876244050     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0061891     Document Type: Article

References (48)

1. Williams JJ, Kaplan GG, Makhija S, Urbanski SJ, Dupre M, et al. (2008) Microscopic colitis-defining incidence rates and risk factors: a population-based study. Clin Gastroenterol Hepatol 6: 35-40.
2. Olesen M, Eriksson S, Bohr J, Jarnerot G, Tysk C, (2004) Microscopic colitis: a common diarrhoeal disease. An epidemiological study in Orebro, Sweden, 1993-1998. Gut 53: 346-350.
3. Abdo AA, Urbanski SJ, Beck PL, (2003) Lymphocytic and collagenous colitis: the emerging entity of microscopic colitis. An update on pathophysiology, diagnosis and management. Can J Gastroenterol 17: 425-432.
4. Lazenby AJ, (2005) Collagenous and lymphocytic colitis. Seminars in diagnostic pathology. 22: 295-300.
5. Pardi DS, Loftus EVJ, Smyrk TC, Kammer P, Tremaine WJ, et al. (2007) The Epidemiology of Microscopic Colitis: a Population-Based Study in Olmsted County, Minnesota. Gut 56: 504-508.
6. Bohr J, Tysk C, Yang P, Danielsson D, Jarnerot G, (1996) Autoantibodies and immunoglobulins in collagenous colitis. Gut 39: 73-76.
7. Kandemir O, Utas C, Gonen O, Patiroglu TE, Ozbakir O, et al. (1995) Colonic subepithelial collagenous thickening in diabetic patients. Dis Colon Rectum 38: 1097-1100.
8. Cindoruk M, Tuncer C, Dursun A, Yetkin I, Karakan T, et al. (2002) Increased colonic intraepithelial lymphocytes in patients with Hashimoto's thyroiditis. J Clin Gastroenterol 34: 237-239.
9. Baert F, Wouters K, D'Haens G, Hoang P, Naegels S, et al. (1999) Lymphocytic colitis: a distinct clinical entity? A clinicopathological confrontation of lymphocytic and collagenous colitis. Gut 45: 375-381.
10. Jarnerot G, Hertervig E, Granno C, Thorhallsson E, Eriksson S, et al. (2001) Familial occurrence of microscopic colitis: a report on five families. Scandinavian J Gastroenterol 36: 959-962.
11. Kaplan GG, Seminowich S, Williams J, Muruve D, Dupre M, et al. (2008) The risk of microscopic colitis in solid-organ transplantation patients: a population-based study. Transplantation 85: 48-54.
12. Beaugerie L, Pardi DS, (2005) Review article: drug-induced microscopic colitis-proposal for a scoring system and review of the literature. Aliment Pharmacol Ther 22: 277-284.
13. Fernandez-Banares F, Esteve M, Espinos JC, Rosinach M, Forne M, et al. (2007) Drug consumption and the risk of microscopic Colitis. Am J Gastroenterol 102: 324-330.
14. Chande N, Driman DK, Reynolds RP, (2005) Collagenous colitis and lymphocytic colitis: patient characteristics and clinical presentation. Scan J Gastroenterol 40: 343-347.
15. Riddell RH, Tanaka M, Mazzoleni G, (1992) Non-steroidal anti-inflammatory drugs as a possible cause of collagenous colitis: a case-control study. Gut 33: 683-686.
16. Bohr J, Tysk C, Eriksson S, Abrahamsson H, Jarnerot G, (1996) Collagenous colitis: a retrospective study of clinical presentation and treatment in 163 patients. Gut 39: 846-851.
17. Koskela RM, Karttunen TJ, Niemelä SE, Lehtola JK, Ilonen J, et al. (2008) Human leucocyte antigen and TNF alpha polymorphism association in microscopic colitis. Eur J Gastroenterol Hepatol 20: 276-282.
18. Koskela RM, Karttunen TJ, Niemelä SE, Lehtola JK, Bloigu RS, et al. (2011) Cytokine gene polymorphism in microscopic colitis association with the IL-6-174 GG genotype. Eur J Gastroenterol Hepatol 7: 607-613.
19. Tagkalidis PP, Gibson PR, Bhathal PS, (2007) Microscopic colitis demonstrates a T helper cell type 1 mucosal cytokine profile. J Clin Pathol 60: 382-387.
20. Stahle-Backdahl M, Maim J, Veress B, Benoni C, Bruce K, et al. (2000) Increased presence of eosinophilic granulocytes expressing transforming growth factor-beta1 in collagenous colitis. Scan J Gastroenterol 35: 742-746.
21. Rask-Madsen J, Grove O, Hansen MG, Bukhave K, Scient C, et al. (1983) Colonic transport of water and electrolytes in a patient with secretory diarrhea due to collagenous colitis. Dig Dis Sci 28: 1141-1146.
22. Wallace JL, (2001) Prostaglandin biology in inflammatory bowel disease. Gastroenterology Clinics of North America 30: 971-980.
23. Hendel J, Nielsen OH, (1997) Expression of cyclooxygenase-2 mRNA in active inflammatory bowel disease. Am J Gastroenterol 92: 1170-1173.
24. Singer, II, Kawka DW, Schloemann S, Tessner T, Riehl T, et al. (1998) Cyclooxygenase 2 is induced in colonic epithelial cells in inflammatory bowel disease. Gastroenterology 115: 297-306.
25. Gustafson-Svard C, Tagesson C, Boll RM, Kald B, (1993) Tumor necrosis factor-alpha potentiates phospholipase A2-stimulated release and metabolism of arachidonic acid in cultured intestinal epithelial cells (INT 407). Scand J Gastroenterol 28: 323-330.
26. Martin M, Neumann D, Hoff T, Resch K, DeWitt DL, et al. (1994) Interleukin-1-induced cyclooxygenase 2 expression is suppressed by cyclosporin A in rat mesangial cells. Kidney International 45: 150-158.
27. Dey I, Lejeune M, Chadee K, (2006) Prostaglandin E2 receptor distribution and function in the gastrointestinal tract. British J Pharmacology 149: 611-623.
28. Srivastava V, Dey I, Leung P, Chadee K, (2012) Prostaglandin E2 modulates IL-8 expression through formation of a multiprotein enhanceosome in human colonic epithelial cells. Eur J Immunol 42: 912-923.
29. Dey I, Giembycz MA, Chadee K, (2009) Prostaglandin E2 couples through EP4 prostanoid receptors to induce IL-8 production in human colonic epithelial cell lines. Br J Pharmacol 156: 475-485.
30. Yu Y, Chadee K, (1998) Prostaglandin E2 stimulates IL-8 gene expression in human colonic epithelial cells by a posttranscriptional mechanism. J Immunol 161: 3746-3752.
31. Sheibanie AF, Yen JH, Khayrullina T, Emig F, Zhang M, et al. (2007) The proinflammatory effect of prostaglandin E2 in experimental inflammatory bowel disease is mediated through the IL-23-->IL-17 axis. J Immunol 178: 8138-8147.
32. Cosme R, Lublin D, Takafuji V, Lynch K, Roche JK, (2000) Prostanoids in human colonic mucosa: effects of inflammation on PGE2 receptor expression. Human Immunology 61: 684-696.
33. Kabashima K, Saji T, Murata T, Nagamachi M, Matsuoka T, et al. (2002) The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut. J Clin Invest 109: 883-893.
34. Jiang GL, Nieves A, Im WB, Old DW, Dinh DT, et al. (2007) The prevention of colitis by E prostanoid receptor 4 agonist through enhancement of epithelium survival and regeneration. J Pharmacol Exp Therap 320: 22-28.
35. Libioulle C, Louis E, Hansoul S, Sandor C, Farnir F, et al. (2007) Novel Crohn disease locus identified by genome-wide association maps to a gene desert on 5p13.1 and modulates expression of PTGER4. PLoS Genetics 20: e58.
36. Olesen M, Eriksson S, Bohr J, Jarnerot G, Tysk C, (2004) Lymphocytic colitis: a retrospective clinical study of 199 Swedish patients. Gut 53: 536-541.
37. Chang F, Deere H, Vu C, (2005) Atypical forms of microscopic colitis: morphological features and review of the literature. Adv Anat Pathol 12: 203-211.
38. Warren BF, Edwards CM, Travis SP, (2002) 'Microscopic colitis': classification and terminology. Histopathology 40: 374-376.
39. El-Salhy M, Gundersen D, Hatlebakk JG, Hausken T, (2012) High densities of serotonin and peptide YY cells in the colon of patients with lymphocytic colitis. World J Gastroenterol 18: 6070-6075.
40. Braegger CP, MacDonald TT, (1994) Immune mechanisms in chronic inflammatory bowel disease. Ann Allergy (72):: 135-134.
41. Ruemmele FM, Seidman EG, (1998) Cytokine-intestinal epithelial cell interactions: implications for immune mediated bowel disorders. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi 39: 1-8.
42. Sugi K, Musch MW, Field M, (2001) Inhibition of Na+, K+-ATPase by interferon gamma down-regulates intestinal epithelial transport and barrier function. Gastroenterology 120: 1393-1403.
43. Burgel N, Bojarski C, Mankertz J, (2002) Mechanisms of diarrhea in collagenous colitis. Gastroenterology 123: 433-443.
44. Soderholm JD, Olaison G, Peterson KH, Franzen LE, Lindmark T, et al. (2002) Augmented increase in tight junction permeability by luminal stimuli in the noninflamed ileum of Crohn's disease. Gut 50: 307-313.
45. Sun Y, Fihn BM, Sjovall H, Jodal M, (2004) Enteric neurones modulate the colonic permeability response to luminal bile acids in rat colon in vivo. Gut 53: 362-367.
46. Nitta M, Hirata I, Toshina K, Murano M, Maemura K, et al. (2002) Expression of the EP4 prostaglandin E2 receptor subtype with rat dextran sodium sulphate colitis: colitis suppression by a selective agonist, ONO-AE1-329. Scand. J. Immunol 56: 66-75.
47. Kunikata T, Tanaka A, Miyazawa T, Kato S, Takeuchi K, (2002) 16, 16-Dimethyl prostaglandin E2 inhibits indomethacin-induced small intestinal lesions through EP3 and EP4 receptors. Dig. Dis. Sci 47: 894-904.
48. Lejeune M, Leung P, Beck PL, Chadee K, (2010) Role of EP4 receptor and prostaglandin transporter in prostaglandin E2-induced alteration in colonic epithelial barrier integrity. Am J Physiol 299: 1097-1105.